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Accurate diagnosis of neurocysticercosis (NCC) is a chal-
lenge. A recent case report published by Rizvi et al. reported that
the diagnosis of NCC in their patient was based on a multi-
lobulated cystic mass in the posteromedial left temporal/occipital
region with surrounding edema seen on computed tomography
(CT) and magnetic resonance imaging (MRI) [1]. This sole
diagnostic criterion may be doubtful when considering that
parenchymal and extraparenchymal NCC are practically
distinct entities from clinical, immunological, and
pathophysiological points of view [2]. Although CT and MRI
are useful in diagnosis of NCC, their utility varies depending
mainly upon the parasite evolutionary stage (vesicular,
colloidal, granular-nodular, and calciﬁed phases). It has been
proposed that visualization of the scolex inside the cysts is a
characteristic image of parenchymal NCC [3]; however,
extraparenchymal NCC is more difﬁcult to detect by imaging
because the attenuation and signal intensity of the cyst's
content is similar to that of CSF. The cystic wall is usually
not detected, and the cysts frequently lack a scolex. MRI
techniques such as ﬂuid-attenuated inversion recovery
(FLAIR), as well as 3D sequences such as Fast Imaging
Employing Steady-state Acquisition (FIESTA), 3D Constructive
Interference in SteadyState (3D-CISS), and 3D SPoiled Gradient
Recalled echo sequences (SPGR), have proven to be useful in
evaluating ventricular cysts and permit better detection of the
parasites [4]. We would recommend that the patient case reported
by Rizvi et al. be re-evaluated using these new MRI techniques
in order to conﬁrm the diagnosis.
Treatment of NCC is complex and should be individualized
according to the location and viability of the parasites [2].
Symptomatic treatment is based upon clinical manifestations:
antiepileptic drugs for seizures, mannitol for high intracranialpressure, and analgesics for headache. Steroids are often
administered to reduce inﬂammation; however, optimal dose,
duration, and timing of administration and discontinuation
remain unknown. Antihelminthic drugs, such praziquantel and
albendazole, (separately or combined) are currently used to
kill the parasite. Clinical trials of parenchymal NCC treatment
using these drugs have shown disappearance of parasites in
about half of the patients; while there are no randomized
controlled trials providing evidence for treatment of
extraparenchymal NCC so far [2]. Neurosurgical intervention
should be considered for hydrocephalus requiring ventriculo-
peritoneal shunt or intraventricular excision of a cyst. In the
case report by Rizvi et al., at the very least it is important to
know how (and if) the cystic mass responded to antihelminthic
treatment on imaging, as this would help to further support a
diagnosis of NCC.
NCC is still an important public health issue worldwide and
is widely prevalent in many countries with high poverty in sub-
Saharan Africa, Asia, and Latin America. Indeed the number of
cases in non-endemic countries has also increased due to inter-
national travel and relocation [2]. Rizvi et al. include a ﬁgure of
“the geographic distribution of NCC,” which is incorrect and not
applicable to the epidemiology of NCC. The World Health
Organization [5] has recently published an updated map of the
approximate distribution of Taenia solium/cysticercosis
(Figure 1) infection, showing a more accurate distribution of
endemic and suspected endemic areas of this parasitic disease
around the world, based on current and reliable epidemiological
data.
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Figure 1. Endemicity of Taenia solium infection, 2015.
Arturo Carpio, Matthew L. Romo/Asian Paciﬁc Journal of Tropical Medicine 2016; 9(8): 821–822822References
[1] Rizvi SA, Saleh AM, Frimpong H, Al Mohiy HM, Ahmed J,
Edwards RD, et al. Neurocysticercosis: a case report and brief re-
view. Asian Pac J Trop Med 2016; 9(1): 100-102.
[2] Carpio A, Romo ML, Parkhouse RM, Short B, Dua T. Parasitic
diseases of the central nervous system: lessons for clinicians and
policy makers. Expert Rev Neurother 2016; 4: 1-14.[3] Zee CS, Go JL, Kim PE, DiGiorgio CM. Imaging of neuro-
cysticercosis. Neuroimag Clin N Am 2000; 10: 391-407.
[4] Carrillo Mezo R, Lara Garcı´a J, Arroyo M, Fleury A. Relevance of
3D magnetic resonance imaging sequences in diagnosing basal
subarachnoid neurocysticercosis. Acta Trop 2015; 152: 60-65.
[5] World Health Organization. Taeniasis/cysticercosis[Online]. Avaliable
at: http://www.who.int/taeniasis/en/ [Accessed on March 8th, 2016].
